Sign Up to like & get
recommendations!
0
Published in 2022 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2022.100980
Abstract: Highlights • AIs may offer prolonged disease stability even in metastatic ESS, but response rates are modest.• After disease progression on one AI, some patients may benefit from trial of a different AI.• Optimal duration…
read more here.
Keywords:
role aromatase;
low grade;
aromatase inhibitors;
inhibitors treatment ... See more keywords